Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Ye Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9918-6498; OpenAlex author ID A5107209328. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

  1. NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response. Co-author DOI 10.3389/fcell.2021.641836↗
  2. Overexpression of pyruvate dehydrogenase phosphatase 1 promotes the progression of pancreatic adenocarcinoma by regulating energy-related AMPK/mTOR signaling. Co-author DOI 10.1186/s13578-020-00457-5↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongqiang Hua · 1 shared paper, 2021 · strength 0.15
  2. Zhouyu Ning · 1 shared paper, 2021 · strength 0.15
  3. Weidong Shi · 1 shared paper, 2021 · strength 0.15
  4. Ke Zhang · 1 shared paper, 2021 · strength 0.15
  5. Luming Liu · 1 shared paper, 2021 · strength 0.15
  6. Huifeng Gao · 1 shared paper, 2020 · strength 0.13
  7. Jiangang Zhao · 1 shared paper, 2020 · strength 0.13
  8. Lianyu Chen · 1 shared paper, 2020 · strength 0.13
  9. Chien‐shan Cheng · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.